MALLORY SMITH: Open Payments
NPI 1720561160 · LISBON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$504 in 20 payments from 11 companies in 2025. Trend: 2023 $190 · 2024 $259 · 2025 $504
Food & beverage: $504
| Company | Payments | Amount |
|---|---|---|
| Sage Therapeutics, LLC | 5 | $120 |
| Biogen, Inc. | 1 | $120 |
| Exeltis, USA Inc. | 4 | $66 |
| MILLICENT US INC | 2 | $44 |
| Supernus Pharmaceuticals, Inc. | 2 | $37 |
| Agios Pharmaceuticals, Inc. | 1 | $26 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| Organon LLC | 1 | $19 |
| Novo Nordisk Inc | 1 | $19 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $16 |
Products named: ZURZUVAE, SLYND, Qelbree, PYRUKYND, INTRAROSA, FEMLYV, CAPLYTA, NEXPLANON.
Industry payments across OH — which companies pay providers there.
